하인두암의 치료성적: 수술 또는 기관보존요법
The Treatment Outcome of Hypopharynx Cancer: Surgery versus Organ Preservation Therapy
1
조회
0
다운로드
4
인용
0
참고문헌
초록
Background and Objectives Hypopharynx cancer usually presents with late stage diseases requiring radical resection including total laryngectomy with reconstruction resulting in severe functional deficits. In order to preserve organ function, chemotherapy in combination with radiotherapy was introduced and it showed similar treatment. The aim of this study is to compare the treatment outcomes of surgery and organ preservation therapy. Subjects and Method A retrospective review of 55 patients who were diagnosed with hypopharynx cancer and underwent curative treatment from 1994 to 2006 was performed. Patients who underwent surgery or surgery plus postoperative radiotherapy were assigned to surgical treatment group and patients who underwent radiotherapy or radiotherapy with chemotherapy were assigned to organ preservation therapy group. Results Surgical treatment group consisted of 29 patients (52.7%) and organ preservation therapy group consisted of 26 patients (47.3%). The overall 5 year survival rate was 34%. The survival rate was decreased significantly according to the N stage (p=0.02). There was no statistically significant difference in 5 year survival rates between the two groups. The larynx preservation rate was 35.8% for the organ preservation therapy group and 44% for the conservation surgery group. Conclusion Treatment of hypopharynx cancer could be individualized according to the status of diseases.
Abstract
Background and Objectives Hypopharynx cancer usually presents with late stage diseases requiring radical resection including total laryngectomy with reconstruction resulting in severe functional deficits. In order to preserve organ function, chemotherapy in combination with radiotherapy was introduced and it showed similar treatment. The aim of this study is to compare the treatment outcomes of surgery and organ preservation therapy. Subjects and Method A retrospective review of 55 patients who were diagnosed with hypopharynx cancer and underwent curative treatment from 1994 to 2006 was performed. Patients who underwent surgery or surgery plus postoperative radiotherapy were assigned to surgical treatment group and patients who underwent radiotherapy or radiotherapy with chemotherapy were assigned to organ preservation therapy group. Results Surgical treatment group consisted of 29 patients (52.7%) and organ preservation therapy group consisted of 26 patients (47.3%). The overall 5 year survival rate was 34%. The survival rate was decreased significantly according to the N stage (p=0.02). There was no statistically significant difference in 5 year survival rates between the two groups. The larynx preservation rate was 35.8% for the organ preservation therapy group and 44% for the conservation surgery group. Conclusion Treatment of hypopharynx cancer could be individualized according to the status of diseases.
참고문헌 (20)
- Hoffman HT, "Hypopharyngeal cancer patient care evaluation", Laryngoscope, 107(8), pp.1005~1017 (1997)
- Sewnaik A, "Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period", Clin Otolaryngol, 30(1), pp.52~57 (2005)
- Gourin CG, "Carcinoma of the hypopharynx", Surg Oncol Clin N Am, 13(1), pp.81~98 (2004)
- "Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer", N Engl J Med, 324(24), pp.1685~1690 (1991), The Department of Veterans Affairs Laryngeal Cancer Study Group
- Forastiere AA, "Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer", N Engl J Med, 349(22), pp.2091~2098 (2003)
- Lefebvre JL, "Laryngeal preservation in head and neck cancer: multidisciplinary approach", Lancet Oncol, 7(9), pp.747~755 (2006)
- Haddad RI, "Recent advances in head and neck cancer", N Engl J Med, 359(11), pp.1143~1154 (2008)
- 임영창, "조기 하인두암의 수술적 후두보존", 대한이비인후과학회지 두경부외과학, 47(3), pp.252~257 (2004), 대한이비인후과학회
- Lefebvre JL, "What is the role of primary surgery in the treatment of laryngeal and hypopharyngeal cancer? Hayes Martin Lecture", Arch Otolaryngol Head Neck Surg, 126(3), pp.285~288 (2000)
- Lefebvre JL, "Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial.", J Natl Cancer Inst, 88(13), pp.890~899 (1996), EORTC Head and Neck Cancer Cooperative Group
- Kim KH, "Neoadjuvant chemotherapy and radiotherapy for the treatment of advanced hypopharyngeal carcinoma", Korean J Otolaryngol-Head Neck Surg, 40(3), pp.429~434 (1997)
- 왕수건, "하인두암에서 선행항암화학요법 후 방사선치료의 의의", 대한이비인후과학회지 두경부외과학, 46(12), pp.1058~1063 (2003), 대한이비인후과학회
- Okamoto M, "Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer", Acta Otolarygol Suppl, (547), pp.11~14 (2002)
- Urba SG, "Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncolocy Group Trial", J Clin Oncol, 23(1), pp.88~95 (2005)
- Samant S, "Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function", Head Neck, 21(7), pp.595~601 (1999)
- Choi EC, "Treatment results and patterns of failure after surgery for the squamous cell carcinoma of hypopharynx", Korean J Otolaryngol-Head Neck Surg, 43(5), pp.528~534 (2000)
- Kraus DH, "Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx", Otolaryngol Head Neck Surg, 116(6), pp.637~641 (1997)
- Plouin-Gaudon I, "Conservation laryngeal surgery for selected pyriform sinus cancer", Eur J Surg Oncol, 30(10), pp.1123~1130 (2004)
- Czaja JM, "Surgical management of early-stage hypopharyngeal carcinoma", Ann Otol Rhinol Laryngol, 106(11), pp.909~913 (1997)
- El-Deiry M, "Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer", Arch Otolaryngol Head Neck Surg, 131(10), pp.879~885 (2005)